SCB Engages with Regenerative Medicine Standards Development Stakeholders at ASGCT

Washington, DC (May 20, 2018) — On May 16, 2018, as part of the 21st Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) in Chicago, Illinois, Nexight Group and SCB conducted a workshop with stakeholders in the regenerative medicine community to gather input on the development of processes and tools that will be used to improve the identification, prioritization, and feasibility assessment of standards needs for regenerative medicine.

SCB Vice President Sven Kili and Nexight Group’s Ross Brindle and Sarah Lichtner offered the participants an overview of the current view of future support from SCB needed to complement, not replace, current standards development organization (SDO) processes. This support—including improving coordination, increasing engagement, and enhancing education and awareness of standards—will be necessary to keep up with the fast-paced growth of the regenerative medicine field, helping the community achieve its full innovation potential and develop a mature and stable technology development and delivery marketplace.

Over 30 conference attendees took part in the workshop discussions, facilitated by Nexight Group, in which they provided feedback on proposed recommendations for improved processes and criteria for regenerative medicine standards development, as well as offered input on how to refine strategies for engaging regenerative medicine stakeholders in the recommended processes. These recommended process improvements covered upstream activities (e.g., identifying and prioritizing standards needs), support during standards development, and downstream activities (e.g., educating and building awareness of standards) once standards have been established.

“We were pleased that so many ASGCT attendees were able to participate in the workshop, as stakeholder input is vital to helping us improve the way in which standards needs in regenerative medicine are addressed,” said Allison Getz, Operations Program Manager for SCB.

To learn about other upcoming workshops and events or to learn more about how you can participate in regenerative medicine standards development, contact SCB or sign up for our e-newsletter (below).